Pluristem (Israel) Today
| PSTI Stock | ILS 2,148 29.00 1.33% |
Performance11 of 100
| Odds Of DistressLess than 31
|
Pluristem is trading at 2148.00 as of the 6th of May 2024, a -1.33 percent down since the beginning of the trading day. The stock's open price was 2177.0. Pluristem has about a 31 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Pluristem are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of November 2023 and ending today, the 6th of May 2024. Click here to learn more.
Pluristem Therapeutics Inc., together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel. PLURISTEM THERAPEU operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 32.35 M outstanding shares. More on Pluristem
Moving together with Pluristem Stock
| 0.68 | BTX | Lineage Cell Therapeutics | PairCorr |
Moving against Pluristem Stock
| 0.77 | BLRX | BioLine RX | PairCorr |
| 0.65 | PPBT | Purple Biotech | PairCorr |
| 0.64 | KTOV | Purple Biotech | PairCorr |
| 0.53 | EVGN | Evogene | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pluristem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pluristem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pluristem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pluristem (PSTI) is traded on Tel Aviv Stock Exchange in Israel and employs 153 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 116.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pluristem's market, we take the total number of its shares issued and multiply it by Pluristem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pluristem operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.35 M outstanding shares.
Pluristem has accumulated about 10.54 M in cash with (30.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Check Pluristem Probability Of Bankruptcy
Ownership AllocationPluristem has a total of 32.35 Million outstanding shares. Pluristem holds 7.28 pct. of its outstanding shares held by insiders and 12.8 pct. owned by third-party entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Pluristem Ownership Details
Pluristem Stock Price Odds Analysis
What are Pluristem's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Pluristem jumping above the current price in 90 days from now is about 7.34%. The Pluristem probability density function shows the probability of Pluristem stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 5.954 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pluristem will likely underperform. In addition to that, pluristem has an alpha of 10.8453, implying that it can generate a 10.85 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Pluristem to move above the current price in 90 days from now is about 7.34 (This Pluristem probability density function shows the probability of Pluristem Stock to fall within a particular range of prices over 90 days) .
Pluristem Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Pluristem market risk premium is the additional return an investor will receive from holding Pluristem long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pluristem. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Pluristem's alpha and beta are two of the key measurements used to evaluate Pluristem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 21.82 | |||
| Semi Deviation | 2.98 | |||
| Standard Deviation | 87.38 | |||
| Variance | 7634.43 |
Pluristem Stock Against Markets
Picking the right benchmark for Pluristem stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pluristem stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pluristem is critical whether you are bullish or bearish towards Pluristem at a given time. Please also check how Pluristem's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pluristem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Pluristem Corporate Management
Elected by the shareholders, the Pluristem's board of directors comprises two types of representatives: Pluristem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pluristem. The board's role is to monitor Pluristem's management team and ensure that shareholders' interests are well served. Pluristem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pluristem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lior Raviv | Chief Officer | Profile | |
| Nimrod Zvi | Chief Officer | Profile | |
| Efrat LivneHadass | VP HR | Profile | |
| Yaacov Yanay | CEO Pres | Profile | |
| Nitsan MD | Chief Officer | Profile |
How to buy Pluristem Stock?
Before investing in Pluristem, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pluristem. To buy Pluristem stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pluristem. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pluristem stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pluristem stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pluristem stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pluristem, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Pluristem?
The danger of trading Pluristem is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pluristem is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pluristem. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pluristem is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pluristem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Pluristem Stock analysis
When running Pluristem's price analysis, check to measure Pluristem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pluristem is operating at the current time. Most of Pluristem's value examination focuses on studying past and present price action to predict the probability of Pluristem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pluristem's price. Additionally, you may evaluate how the addition of Pluristem to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |